JOEL N KLINE, MD
Medical Practice at Hawkins Dr, Iowa City, IA
License number
Iowa 27469
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Iowa 27469
Category
Osteopathic Medicine
Type
Pulmonary Disease
License number
Iowa 27469
Category
Medical Practice
Type
Preventive Medicine/Occupational Environmental Medicine
Address
Address
200 Hawkins Dr, Iowa City, IA 52242
Phone
(319) 353-8551
(319) 353-6406 (Fax)
(319) 353-6406 (Fax)
Organization information
See more information about JOEL N KLINE at bizstanding.comJoel N Kline
University Of Iowa 200 Hw, Iowa City, IA 52242
Categories:
Research & Development Services
Phone:
(319) 353-8551 (Phone)
University-Ia Hospitals - Joel N Kline MD
200 Hawkins Dr, Iowa City, IA 52242
Categories:
Government Contractors, Pulmonary & Respiratory Physicians & Surgeons
Phone:
(319) 353-8551 (Phone), (800) 777-8442 (Free)
Professional information
Joel N Kline, Iowa City IA
Specialties:
Pulmonologist
Address:
200 Hawkins Dr, Iowa City, IA 52242
Education:
Brown University, Warren Alpert Medical School - Doctor of Medicine
San Joaquin Valley Rehab Hospital - Residency - Internal Medicine
San Joaquin Valley Rehab Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Joel Nathan Kline, Iowa City IA
Specialties:
Internal Medicine, Critical Care Medicine, Pulmonary Disease, Preventive Medicine/Occupational Environmental Medicine
Work:
University Of Iowa Hospital & Clinic
200 Hawkins Dr, Iowa City, IA 52243
200 Hawkins Dr, Iowa City, IA 52243
Education:
Brown University (1986)
Immunostimulatory Nucleic Acid Molecules
US Patent:
2005005, Mar 17, 2005
Filed:
Jul 2, 2004
Appl. No.:
10/884852
Inventors:
Arthur Krieg - Wellesley MA, US
Joel Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Alfred Steinberg - Potomac MD, US
Joel Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Alfred Steinberg - Potomac MD, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
Coley Pharmaceutical Group, Inc. - Wellesley MA
United States of America, as represented by the Secretary Department of Health & Human Services - Bethesda MD
Coley Pharmaceutical Group, Inc. - Wellesley MA
United States of America, as represented by the Secretary Department of Health & Human Services - Bethesda MD
International Classification:
A61K048/00
US Classification:
514044000
Abstract:
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
Immunostimulatory Nucleic Acid Molecules
US Patent:
2009020, Aug 13, 2009
Filed:
Oct 9, 2008
Appl. No.:
12/248493
Inventors:
Arthur M. Krieg - Wellesley MA, US
Joel N. Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Joel N. Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
The US, as represented by the Department of Health and Human Services - Bethesda MD
The US, as represented by the Department of Health and Human Services - Bethesda MD
International Classification:
A61K 39/00
US Classification:
4241841
Abstract:
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
Immunostimulatory Nucleic Acid Molecules
US Patent:
7517861, Apr 14, 2009
Filed:
Jul 9, 2004
Appl. No.:
10/888785
Inventors:
Arthur M. Krieg - Wellesley MA, US
Joel N. Kline - Iowa City IA, US
Joel N. Kline - Iowa City IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A61K 39/00, A61K 39/38, A61K 45/00, A61K 47/00, A61K 9/127, A61K 9/52, A61K 9/16, A61K 9/50, A61K 31/70, A01N 25/08, A01N 43/04, A61F 13/00
US Classification:
514 44, 4241841, 4242821, 4242781, 424409, 424434, 424450, 424457, 424490
Abstract:
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
Immunostimulatory Nucleic Acid Molecules
US Patent:
2003005, Mar 13, 2003
Filed:
Mar 27, 2001
Appl. No.:
09/818918
Inventors:
Arthur Krieg - Iowa City IA, US
Joel Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Alfred Steinberg - Potomac MD, US
Joel Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Alfred Steinberg - Potomac MD, US
International Classification:
A61K048/00
US Classification:
514/044000
Abstract:
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
Immunostimulatory Nucleic Acid Molecules
US Patent:
2005005, Mar 10, 2005
Filed:
Jul 16, 2004
Appl. No.:
10/894657
Inventors:
Arthur Krieg - Wellesley MA, US
Joel Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Alfred Steinberg - Potomac MD, US
Joel Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Alfred Steinberg - Potomac MD, US
Assignee:
The University of Iowa Research Foundation - Iowa City IA
Coley Pharmaceutical Group, Inc. - Wellesley MA
United States of America, as represented by the Secretary, Department of Health & Human Services - Bethesda MD
Coley Pharmaceutical Group, Inc. - Wellesley MA
United States of America, as represented by the Secretary, Department of Health & Human Services - Bethesda MD
International Classification:
A61K048/00
US Classification:
514044000
Abstract:
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
Immunostimulatory Nucleic Acid Molecules
US Patent:
2008002, Jan 31, 2008
Filed:
Jun 5, 2007
Appl. No.:
11/810353
Inventors:
Arthur Krieg - Wellesley MA, US
Joel Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Joel Kline - Iowa City IA, US
Dennis Klinman - Potomac MD, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
The US, as represented by the Department of Health and Human Services - Bethesda MD
The US, as represented by the Department of Health and Human Services - Bethesda MD
International Classification:
A61K 31/7088, A61K 39/35, A61P 37/04
US Classification:
424275100, 514044000
Abstract:
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
Immunostimulatory Nucleic Acid Molecules
US Patent:
7402572, Jul 22, 2008
Filed:
Apr 23, 2004
Appl. No.:
10/831647
Inventors:
Arthur M. Krieg - Wellesley MA, US
Joel N. Kline - Iowa City IA, US
Joel N. Kline - Iowa City IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A01N 43/04, A61K 31/70, A61K 45/00, A61K 47/00, C07H 21/02, C07H 21/04
US Classification:
514 44, 536 231, 4242781
Abstract:
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
Methods Of Treating Pulmonary Diseases And Disorders By Modulating Calcium/Calmodulin Dependent Protein Kinase Ii Activity
US Patent:
8440656, May 14, 2013
Filed:
Jun 22, 2010
Appl. No.:
12/820802
Inventors:
Mark E. Anderson - Iowa City IA, US
Isabella M. Grumbach - Iowa City IA, US
Joel N. Kline - Iowa City IA, US
Isabella M. Grumbach - Iowa City IA, US
Joel N. Kline - Iowa City IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A61K 31/54, A61K 31/44, A61K 31/40, A61K 31/19, A61K 31/195
US Classification:
5142265, 514334, 514420, 514557, 514567
Abstract:
Disclosed are methods of treating or preventing a pulmonary disease or disorder in a subject, the methods comprising administering an effective amount of an compound that inhibits Calmodulin Kinase II (CaMKII) activity, either directly or indirectly, thereby treating or preventing the pulmonary disease or disorder in the subject.